![Takashi Shimada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Takashi Shimada
President bij
PHOENIXBIO CO., LTD.
Vermogen: 181 487 $ op 31-05-2026
Profiel
Takashi Shimada is currently Chairman at KMT Hepatech, Inc. since 2017, Chairman at PhoenixBio USA Corp.
since 2018, and President & Representative Director at PhoenixBio Co., Ltd. since 2018.
Formerly, Mr. Shimada was Director & Administration Manager at Institute of Immunology Co., Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHOENIXBIO CO., LTD. 1,68% | 30-09-2025 | 68.300 ( 1,68% ) | 181 487 $ | 31-05-2026 |
Actieve functies van Takashi Shimada
| Bedrijven | Functie | Begin |
|---|---|---|
| PHOENIXBIO CO., LTD. | President | 28-06-2018 |
PhoenixBio USA Corp.
 PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Voorzitter | 01-06-2018 |
KMT Hepatech, Inc.
 KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Voorzitter | 01-12-2017 |
Eerdere bekende functies van Takashi Shimada
| Bedrijven | Functie | Einde |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Develops and produces diagnostic reagents and monoclonal antibodies | Hoofd Administratief Officier | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Commercial Services |
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Develops and produces diagnostic reagents and monoclonal antibodies | Health Technology |
PhoenixBio Co., Ltd.
 PhoenixBio Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
PhoenixBio USA Corp.
PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
